Results 41 to 50 of about 26,279 (218)

Multimodal imaging of experimental choroidal neovascularization. [PDF]

open access: yes, 2022
AIM To compare choroidal neovascularization (CNV) lesion measurements obtained by in vivo imaging modalities, with whole mount histological preparations stained with isolectin GS-IB4, using a murine laser-induced CNV model.
Liu, Xuan   +5 more
core   +1 more source

Risk factors for the development of subretinal fluid in the fellow eyes of patients with chronic central serous chorioretinopathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess the risk of subretinal fluid (SRF) development in the fellow eye of chronic central serous chorioretinopathy (cCSC) patients with unilateral SRF at baseline. Methods Medical records of 334 presumed cCSC patients were retrospectively reviewed.
Helena M. A. Feenstra   +4 more
wiley   +1 more source

Clinical and angiographic characterization of choroidal neovascularization in diabetic retinopathy

open access: yes, 2021
Background: To report the clinical and angiographic characteristics of choroidal neovascularization in patients with diabetic retinopathy. Methods: Patients of type 2 diabetes mellitus with presence of choroidal neovascularization in at least one eye ...
Chhablani J.   +4 more
core   +1 more source

Dataset of plasma and aqueous humor cytokine profiles in patients with exudative age related macular degeneration and polypoidal choroidal vasculopathy

open access: yesData in Brief, 2018
In this report the data was obtained from a prospective case-control study with a sample size of sixteen patients with exudative age related macular degeneration (AMD) due to choroidal neovascularization (CNV) and eighteen patients with polypoidal ...
Praveen Kumar Balne   +8 more
doaj   +1 more source

Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Assessing the 24‐month treatment outcome of half‐dose photodynamic therapy (PDT) or oral eplerenone in chronic central serous chorioretinopathy (cCSC). Methods Multicentre randomized clinical trial included cCSC patients from the SPECTRA trial who were randomized to receive half‐dose PDT or oral eplerenone.
Helena M. A. Feenstra   +8 more
wiley   +1 more source

Imaging the Choroid and Choroidal Neovascularization in Eyes with Inflammation [PDF]

open access: yesOcular Immunology and Inflammation, 2016
The choroidal vasculature is the primary source of both oxygen and blood-borne nutrients to the outer retina, including the retinal pigment epithelium (RPE), photoreceptors, and otherwise avascular...
Emmett T, Cunningham   +4 more
openaire   +2 more sources

The impacts of high refractive errors on self‐reported visual function and visual concern

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To examine the association between refractive errors and self‐reported visual function and visual concern, considering self‐perceived present eyesight, concerns about vision, accomplishing less and limitations in daily activities in an eye‐healthy cohort.
Jens Riis Møller   +9 more
wiley   +1 more source

Association of treated neovascular AMD with disability and mood disorders: A longitudinal nationwide study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To describe the associations of treated neovascular AMD with the risk of disability, falls, fractures and mood disorders in a large sample representative of the French population. Methods Analyses were based on 77 582 individuals belonging to the ‘Echantillon Généraliste des Bénéficiaires’, a 1/97 random sample of the French population,
Cécile Delcourt   +6 more
wiley   +1 more source

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car   +3 more
wiley   +1 more source

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization

open access: yesPatologìâ, 2013
Nowadays, new methods of treatment of choroidal neovascularization are being actively developed and introduced in exudative form of age-related macular degeneration (AMD), complicated myopia, diabetic retinopathy and post-thrombotic retinopathy ...
N. G. Zavgorodnya   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy